Next generation of immune checkpoint therapy in cancer: new developments and challenges.

Marin-Acevedo, Julian A; Dholaria, Bhagirathbhai; Soyano, Aixa E; Knutson, Keith L; Chumsri, Saranya; Lou, Yanyan

Marin-Acevedo, Julian A; Dholaria, Bhagirathbhai; Soyano, Aixa E; Knutson, Keith L; Chumsri, Saranya; Lou, Yanyan.

Afiliación

Marin-Acevedo JA; Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Dholaria B; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
Soyano AE; Present Address: Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
Knutson KL; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
Chumsri S; Division of Immunology, Mayo Clinic, Jacksonville, FL, USA.
Lou Y; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.

J Hematol Oncol ; 11(1): 39, 2018 03 15.

Article en En | MEDLINE | ID: mdl-29544515

Asunto(s)

Inmunoterapia/métodos; Neoplasias/terapia; Receptor de Muerte Celular Programada 1/antagonistas & inhibidores; Humanos

Palabras clave

Cancer; Co-stimulatory pathways; Cytotoxic T lymphocytes; Immune checkpoint therapy; Immune evasion; Immunotherapy; Inhibitory pathways; Tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google